本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1998/6/11 分钟阅读
Implantation or Injectable Dosage Form New Animal Drugs; Lufenuron Suspension
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The NADA provides for subcutaneous use of lufenuron suspension in cats for control of flea populations.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →